Hematologic Malignancies

Showing 51 - 75 of 136

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Hematologic Malignancies Trial in Houston (TAPA-pulsed DC vaccine)

Withdrawn
  • Cancer
  • Hematologic Malignancies
  • TAPA-pulsed DC vaccine
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2019

Hematologic Malignancies Trial in Maywood (StemEx)

Completed
  • Hematologic Malignancies
  • StemEx
  • Maywood, Illinois
    Loyola University Medical Center
Aug 19, 2019

Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,

Completed
  • Advanced Solid Malignancies
  • Hematologic Malignancies
  • Fort Myers, Florida
  • +2 more
Jun 28, 2019

Hematologic Malignancies Trial in Durham (Home Care)

Completed
  • Hematologic Malignancies
  • Home Care
  • Durham, North Carolina
    Duke University Medical Center
Jul 15, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

Completed
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Aurora, Colorado
  • +5 more
Mar 6, 2019

Cancer Patients' Performance Status Assessed Using

Completed
  • Malignant Solid Tumor
  • Hematologic Malignancies
  • Biometric Devices
  • Physical Performance Testing
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Feb 21, 2019

Exercise Capacity and Physical Activity Levels in Newly

Completed
  • Hematologic Malignancies
    • Yenimahalle, Turkey
      Gazi University Faculty of Health Sciences Department of Physica
    Feb 13, 2019

    Hematologic Malignancies Trial in Bergamo, Bolzano, Monza (in vitro expanded Cytokine Induced Killer (CIK) cells)

    Completed
    • Hematologic Malignancies
    • in vitro expanded Cytokine Induced Killer (CIK) cells
    • Bergamo, Italy
    • +2 more
    Jan 17, 2019

    Hematologic Malignancies Trial in Italy (UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC))

    Unknown status
    • Hematologic Malignancies
    • UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)
    • Bergamo, Italy
    • +7 more
    Jan 17, 2019

    Tumors, Hematologic Malignancies Trial in Worldwide (Atezolizumab)

    Completed
    • Tumors
    • Hematologic Malignancies
    • Scottsdale, Arizona
    • +20 more
    Dec 10, 2018

    Hematologic Malignancies Trial in Houston (Tezacitabine (FMdC))

    Completed
    • Hematologic Malignancies
    • Tezacitabine (FMdC)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Oct 31, 2018

    Hematologic Malignancies Trial in Duarte, Boston (Biological: ProHema-CB)

    Terminated
    • Hematologic Malignancies
    • Biological: ProHema-CB
    • Duarte, California
    • +1 more
    Feb 28, 2018

    Hematologic Malignancies Trial in Marseille (Monalizumab)

    Unknown status
    • Hematologic Malignancies
    • Marseille, Bouches Du Rhônes, France
      Institut Paoli Calmettes
    Sep 18, 2018

    Cancer, Hematologic Malignancies Trial (TAPA-pulsed DC vaccine)

    Withdrawn
    • Cancer
    • Hematologic Malignancies
    • TAPA-pulsed DC vaccine
    • (no location specified)
    Aug 24, 2018

    Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Hematologic Malignancies
    • San Francisco, California
    • +4 more
    May 15, 2018

    Hematologic Malignancies Trial in Lebanon (Pegfilgrastim)

    Terminated
    • Hematologic Malignancies
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Mar 22, 2018

    Physical Fitness in Cancer Cardiopulmonary Exercise Testing and

    Completed
    • Malignant Solid Tumour
    • +2 more
    • Physical performance testing and patient-generated health data
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Mar 21, 2018

    Pre-transplant Comorbidities and Post-transplant Toxicities and

    Completed
    • Hematologic Malignancies
    • Other Diagnoses, Comorbidities, and Complications
      • Seattle, Washington
        Fred Hutchinson Cancer Research Center
      Jan 9, 2018

      Hematologic Malignancies Trial in Minneapolis (biological, drug, radiation)

      Withdrawn
      • Hematologic Malignancies
      • T Regulatory cells
      • +3 more
      • Minneapolis, Minnesota
        University of Minnesota Masonic Cancer Center
      Nov 29, 2017

      Cancer, Hematologic Malignancies, Leukemia Trial in Stony Brook, Cleveland, Houston (Arm 1- Dose Escalation, Arm 2- Dose

      Completed
      • Cancer
      • +3 more
      • Arm 1- Dose Escalation
      • Arm 2- Dose Expansion
      • Stony Brook, New York
      • +2 more
      Nov 1, 2017

      Hematologic Malignancies Trial in Seoul (Matching on the basis of molecular analysis, Matching on the basis of physician's

      Unknown status
      • Hematologic Malignancies
      • Matching on the basis of molecular analysis
      • Matching on the basis of physician's choice
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Oct 24, 2017

      Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)

      Terminated
      • Hematologic Malignancies
      • Granulocyte Colony Stimulating Factor
      • Atlanta, Georgia
        Children's Healthcare of Atlanta/Emory University
      Aug 10, 2017

      T Cell and Natural Killer Cell in Relation to Viral Infections

      Completed
      • Hematologic Malignancies
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Jul 14, 2017

        Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Bz (Bortezomib), Len (lenalidomide))

        Completed
        • Hematologic Malignancies
        • Multiple Myeloma
        • Bz (Bortezomib)
        • Len (lenalidomide)
        • Würzburg,, Germany
        • +9 more
        Jul 5, 2017